Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.

MLA

King, Jennifer, et al. “Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.” JAMA Oncology, vol. 10, no. 1, Jan. 2024, pp. 132–34. EBSCOhost, https://doi.org/10.1001/jamaoncol.2023.4949.

APA

King, J., Ashkar, R., Kesler, K., Althouse, S. K., Hanna, N. H., Einhorn, L. H., & Adra, N. (2024). Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors. JAMA Oncology, 10(1), 132–134. https://doi.org/10.1001/jamaoncol.2023.4949

Chicago

King, Jennifer, Ryan Ashkar, Kenneth Kesler, Sandra K. Althouse, Nasser H. Hanna, Lawrence H. Einhorn, and Nabil Adra. 2024. “Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.” JAMA Oncology 10 (1): 132–34. doi:10.1001/jamaoncol.2023.4949.